Jean B Nachega, MD, PhD, MPH,

Associate Professor, Infectious Diseases and Microbiology

Associate Professor, Epidemiology


R-znvy: woa61@cvgg.rqh
Primary Phone: 967-179-6044

Personal Statement

Jean Nachega, MD, PhD, MPH, FRCP: Associate Professor of Medicine,
Infectious Diseases, Microbiology and Epidemiology, at Graduate School of
Public Health, Pittsburgh University. Dr Nachega is also an Adjunct Associate
Professor of Epidemiology and International Health at Johns Hopkins Bloomberg School of Public Health; and Professor Extraordinary of Medicine and Director of the Center for Infectious Diseases, at Stellenbosch University, Cape Town, South Africa. He received his training in Belgium (University of Louvain), UK (London School of Hygiene & Tropical Medicine), USA (Johns Hopkins University & Harvard University). He has over 25 year-experience in patient care, teaching, designing and implementing HIV/AIDS and Tuberculosis studies or programs funded by NIH/NIAID, PEPFAR, EDCTP, and Wellcome Trust. He is a lead HIV Investigator within AIDS Clinical Trial Group (ACTG) and an ad hoc consultant at WHO, CDC, Bill and Melinda Gates Foundation, as well as a member of Academy of Sciences of South Africa (ASSAf) and African Academy of Sciences (AAS)



1985 \ Facultes Universitaires Notre Dame de la Paix, Namur, Belgium\ BS (Cum Laude)
1989 \ University Catholic of Louvain, Brussels, Belgium \ MD (Cum Laude)
1999 \ Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA \ MPH
2000 \ London School of Hygiene & Tropical Medicine, London, UK \ DTM&H
2008 \ University of Cape Town, South Africa \ PhD
2010 \ Harvard School of Public Health, Boston, MA, USA \ John  McGoldrick Fellow in Biostat in AIDS Research, Decision Analysis and Health Economics


•     Primary Instructor, EPIDEM2166, Global Control of Tuberculosis and HIV, SUMMER term, Level: 2013, 6 students, 2.0 contact hours, Tues & Thurs, 4 weeks (One Credit)

Selected Publications

1: Nakimuli-Mpungu E, Musisi S, Smith CM, Von Isenburg M, Akimana B, Shakarishvili A, Nachega JB, Mills EJ, Chibanda D, Ribeiro M, V Williams A, Joska JA. Mental health interventions for persons living with HIV in low- and middle-income countries: a systematic review. J Int AIDS Soc. 2021 Jun;24 Suppl 2:e25722. doi: 10.1002/jia2.25722. PMID: 34164926.


2: Park JJH, Mogg R, Smith GE, Nakimuli-Mpungu E, Jehan F, Rayner CR, Condo J, Decloedt EH, Nachega JB, Reis G, Mills EJ. How COVID-19 has fundamentally changed clinical research in global health. Lancet Glob Health. 2021 May;9(5):e711-e720. doi: 10.1016/S2214-109X(20)30542-8. PMID: 33865476; PMCID: PMC8049590.


3: Park JJH, Grais RF, Taljaard M, Nakimuli-Mpungu E, Jehan F, Nachega JB, Ford N, Xavier D, Kengne AP, Ashorn P, Socias ME, Bhutta ZA, Mills EJ. Urgently seeking efficiency and sustainability of clinical trials in global health. Lancet Glob Health. 2021 May;9(5):e681-e690. doi: 10.1016/S2214-109X(20)30539-8. PMID: 33865473.


4: Nachega JB, Sam-Agudu NA, Mellors JW, Zumla A, Mofenson LM. Scaling Up Covid-19 Vaccination in Africa - Lessons from the HIV Pandemic. N Engl J Med. 2021 Mar 31. doi: 10.1056/NEJMp2103313. Epub ahead of print. PMID: 33789005.


5: Nachega JB, Maeurer M, Sam-Agudu NA, Chakaya J, Katoto PDM, Zumla A. Bacille Calmette-Guérin (BCG) vaccine and potential cross-protection against SARS-CoV-2 infection - Assumptions, knowns, unknowns and need for developing an accurate scientific evidence base. Int J Infect Dis. 2021 Mar 29:S1201-9712(21)00279-4. doi: 10.1016/j.ijid.2021.03.060. Epub ahead of print. PMID: 33794380; PMCID: PMC8006492.


6: Nachega JB, Kapata N, Sam-Agudu NA, Decloedt EH, Katoto PDMC, Nagu T, Mwaba P, Yeboah-Manu D, Chanda-Kapata P, Ntoumi F, Geng EH, Zumla A. Minimizing the impact of the triple burden of COVID-19, tuberculosis and HIV on health services in sub-Saharan Africa. Int J Infect Dis. 2021 Mar 20:S1201-9712(21)00256-3. doi: 10.1016/j.ijid.2021.03.038. Epub ahead of print. PMID: 33757874; PMCID: PMC7980520.


7: Zumla A, Chakaya J, Khan M, Fatima R, Wejse C, Al-Abri S, Fox GJ, Nachega J, Kapata N, Knipper M, Orcutt M, Goscé L, Abubakar I, Nagu TJ, Mugusi F, Gordon AK, Shanmugam S, Bachmann NL, Lam C, Sintchenko V, Rudolf F, Amanullah F, Kock R, Haider N, Lipman M, King M, Maeurer M, Goletti D, Petrone L, Yaqoob A, Tiberi S, Ditiu L, Sahu S, Marais B, Issayeva AM, Petersen E. World Tuberculosis Day 2021 Theme - 'The Clock is Ticking' - and the world is running out of time to deliver the United Nations General Assembly commitments to End TB due to the

COVID-19 pandemic. Int J Infect Dis. 2021 Mar 18:S1201-9712(21)00264-2. doi: 10.1016/j.ijid.2021.03.046. Epub ahead of print. PMID: 33746094.


8: Nachega JB, Borre ED, Dowdy DW, Chanda-Kapata P, Cleary S, Geng EH. Cost- effectiveness of universal HIV testing and treatment: where next? Lancet Glob Health. 2021 May;9(5):e573-e574. doi: 10.1016/S2214-109X(21)00089-9. Epub 2021 Mar 12. PMID: 33721567.


9: Chakaya J, Khan M, Ntoumi F, Aklillu E, Fatima R, Mwaba P, Kapata N, Mfinanga S, Hasnain SE, Katoto PDMC, Bulabula ANH, Sam-Agudu NA, Nachega JB, Tiberi S, McHugh TD, Abubakar I, Zumla A. Global Tuberculosis Report 2020 - Reflections on the Global TB burden, treatment and prevention efforts. Int J Infect Dis. 2021 Mar 11:S1201-9712(21)00193-4. doi: 10.1016/j.ijid.2021.02.107. Epub ahead of print. PMID: 33716195.


10: Nachega JB, Sam-Agudu NA, Masekela R, van der Zalm MM, Nsanzimana S, Condo J, Ntoumi F, Rabie H, Kruger M, Wiysonge CS, Ditekemena JD, Chirimwami RB, Ntakwinja M, Mukwege DM, Noormahomed E, Paleker M, Mahomed H, Tamfum JM, Zumla A, Suleman F. Addressing challenges to rolling out COVID-19 vaccines in African countries. Lancet Glob Health. 2021 Jun;9(6):e746-e748. doi:10.1016/S2214-109X(21)00097-8. Epub 2021 Mar 10. PMID: 33713633; PMCID: PMC7946417.

Jean B Nachega